baber/WOPTO huggingface dataset:
Patent MX-2011000728-A (MX)
Title: Multistandard coding device for 3d video signals.
Inventor: KERBIRIOU PAUL
IPC: H04N13/00
Filed: 2009-07-21
Abstract: The device is characterized in that it comprises the means to generate a stream structured on several levels: a level 0 comprising two independent layers, a base layer containing the video data of the right image and a level 0 enhancement layer containing the video data of the left image, or conversely, a level 1 comprising two independent enhancement layers, a first level 1 enhancement layer containing a depth map relating to the image of the base layer, a second level 1 enhancement layer containing a depth map relating to the level 0 enhancement layer image, a level 2 comprising a level 2 enhancement layer containing occlusion data relating to the base layer image. Applications for coding 3D data relating to 3D digital cinema, 3D DVD, 3D TV, etc.
Patent MX-2011001477-A (MX)
Title: Treatment of autoimmune and inflammatory disease.
Inventor: LEUNG STEWART
IPC: A61P25/00
Filed: 2009-08-07
Abstract: The present invention provides novel methods of treatment of multiple sclerosis and other autoimmune diseases or inflammatory disorders, and antagonists, including isolated binding proteins for use in the novel methods. There is provided a method of treating multiple sclerosis comprising the neutralization of the biological activity of IL-7 by binding to CD127 or IL-7. The isolated binding proteins may also neutralize the biological activity of TSLP.
Patent MX-2011005824-A (MX)
Title: Central vacuum cooling plant.
Inventor: SCHWARTZ LOUIS S
IPC: B65D81/20
Filed: 2011-06-02
Abstract: Described is a method as well as an apparatus for vacuum cooling of food produce through moisture removal, which method comprising the steps of loading the food produce to be cooled into a vacuum chamber, lowering the pressure inside the vacuum chamber to a predetermined pressure level and maintaining the vacuum chamber at this predetermined pressure level both by removing air through a vacuum pump system for a sufficient of time to allow heat transfer out of the food produce to take place, and condensing water vapor inside the vacuum chamber through a refrigeration system. The method and apparatus is unique in that the step of lowering the pressure inside the vacuum chamber to the predetermined pressure level is carried out using a single stage vacuum pump and the step of maintaining the vacuum chamber at this predetermined pressure level is carried out using a two stage vacuum pump. There is obtained a significant energy saving, which mainly is caused by splitting up the pressure lo wering and maintaining steps into two distinct phases in which specifically sized vacuum pumps are used to most efficiently draw the required vacuum during the cooling process. Thus, the single stage vacuum pump used for the pressure lowering step has no high pressure stage that is idling during this step, meaning there is a net power saving or alternatively an increase in performance. Further, the two stage vacuum pump maintaining the pressure in the vacuum chamber for the required duration may be very small having very low displacement and thus low power consumption. In addition, splitting up the pressure lowering and maintaining steps into two distinct phases makes it possible to operate more vacuum chambers simultaneously in any combination, i.e. where some vacuum chambers are in the pressure lowering step others may be in the pressure maintaining step.
Patent MX-2011006467-A (MX)
Title: Training device for training a body part of a user.
Inventor: DER MEER AUGUSTINUS LEONARDUS NICOLAAS VAN
IPC: A63B21/02
Filed: 2008-12-17
Abstract: A training device for training a body part of a user, comprising a vibrating device for generating a vibration, a pretensioning device for generating a pre-tension in a muscle of the body part, wherein said pretensioning device is connected to the vibrating device and comprises a handling member configured to be held by the user, a reeling means for reeling a flexible coupling member, which coupling member couples the handling member to the reeling means, and a tensioning means for driving the reeling means such that in use the coupling member is tensioned for transferring the vibration generated by the vibrating device to the handling member, wherein the tensioning means comprises a fluid resistance means configured to provide a resistance against the unreeling of the coupling member, and also a pretensioning device, method and use.
Patent MX-2011010423-A (MX)
Title: Suspension device.
Inventor: AKEDA MAMORU
IPC: B60G11/04
Filed: 2010-03-19
Abstract: A suspension device (100) is provided with: a leaf spring (110) having front and rear ends which are rotatably supported by a frame (2) of a vehicle (1) and also having a longitudinally intermediate section affixed to an axle (3); and a stay (160) having a catch section (161) which, when that portion of the leaf spring (110) which is behind the intermediate section is broken, restricts the rotation of that portion of the leaf spring (110) which is behind the broken section.
Patent MX-2011011074-A (MX)
Title: Flow-measurement ultrasonic device applied in field and method for determining the transit times.
Inventor: OLMEDO ANTONIO ESPINOSA
IPC: G01F1/66
Filed: 2011-10-19
Abstract: The present invention refers to a flow-measurement ultrasonic device applied in field, which is characterised in that it is a high resolution device of low level of filtrated noises, which provides an improved-quality flow measurement, and which comprises a cabinet including a chassis therein for supporting elements for operating and controlling the device, such as a touch screen, a general purpose microprocessor, a first configuration port, a second configuration port, a digital signal processor (DSP) connected to a field programmable gate array (FPGA) which interacts with the DSP and with a digital-analogue conversion system, also including a transmission-reception switch to which pairs of ultrasonic transducers are connected, also referring to a method for determining the transit times tAB and tBA from the flow measurement ultrasonic device applied in field.
Patent MX-2011011122-A (MX)
Title: Agglomerate formulations including active pharmaceutical agents with targeted particle sizes.
Inventor: PANDEY PREETANSHU
IPC: A61K9/72
Filed: 2010-04-23
Abstract: Various embodiments of the present invention provide for an agglomerate comprising at least one active pharmaceutical agent and at least one excipient; wherein at least about ninety percent of the at least one active pharmaceutical agent have a particle size of less than about 2Âmum.
Patent MX-2012000185-A (MX)
Title: Novel thiophene carboxamide derivative and medicinal use of same.
Inventor: LANGER MARTIN
IPC: A61P27/02
Filed: 2010-06-26
Abstract: Disclosed is a compound having an effect of activating glucokinase. A medicinal composition which comprises, as the active ingredient, a compound represented by general formula (I) or a pharmacologically acceptable salt of the same. In general formula (I), X represents a nitrogen atom or CR<sup>6</sup> wherein R<sup>6</sup> represents a hydrogen atom or a halogen atom; R<sup>1</sup> represents a hydrogen atom, a C<sub>1-6</sub> alkyl group, a C<sub>1-6</sub> alkoxy group or a C<sub>1-6</sub> alkylthio group; R<sup>2</sup> represents a hydrogen atom or a fluorine atom; R<sup>3</sup> represents a hydrogen atom or a C<sub>1-6</sub> alkyl group; and one of R<sup>4</sup> and R<sup>5</sup> represents a hydrogen atom or a C<sub>1-6</sub> alkyl group while the other represents a C<sub>1-6</sub> alkylene carboxylic acid, a C<sub>1-6</sub> alkylsulofonyl group, a C<sub>1-6</sub> alkylcarbonyl group or CONH<sub>2</sub>.
Patent MX-2012000395-A (MX)
Title: Conserved escherichia coli immunogens.
Inventor: SERINO LAURA
IPC: C07K14/245
Filed: 2010-07-07
Abstract: Homologs of the E. coli proteins orf353, bacterial lg-like domain (group 1) protein (orf405), flu antigen 43 (orfl 364), NodT-family outer-membrane-factor-lipoprotein efflux transporter (orfl 767), gspK (orf3515), gspJ (orf3516), toriB-dependent siderophore receptor (orO597), fibrial protein (orf3613), upec-948, upec- 1232. A chain precursor of the type- 1 fimbria! protein (upec- 1875), yapH homolog (upec-2820), hemolysin A (recp-3768), and Sel l repeat-containing protein (upec-521 1 ) from several pathogenic strains of E. coli have been identified with regions within the proteins that are conserved across all E. coli. Fragments corresponding to the conserved regions, especially immunogenic fragments such a linear B-epitopes, are provided. In addition, variants of the bacterial lg-l ike domain (group 1 ) protein (orf405), yapH homolog (upec2820) and two different fragments of hemolysin A (recp3768) are provided herein that have increased solubility as compared to the native protein where the variants still raise a substantially similar immune response in a subject as the corresponding native protein.
Patent MX-2012000646-A (MX)
Title: Concentrate for producing a cooling and release agent or a cooling and lubricating agent and such cooling and release agents and cooling and lubricating agents.
Inventor: LAUDENKLOS MANFRED
IPC: C10M173/02
Filed: 2010-07-02
Abstract: Known cooling and release agents or lubricating agents are not biodegradable and tend to form undesired layer buildup when applied repeatedly to the casting die. The invention therefore proposes using a concentrate for producing a cooling and release agent for reusable casting dies, particularly steel casting dies, or a cooling and lubricating agent, particularly for machining, having an active substance dissolved in water and comprising a protein having a weight proportion of 10% to 50%. Good releasability of the cast parts from the casting die and a good cooling effect on the casting die are obtained using such a cooling and release agent or lubricating agent. Said agent is further biodegradable.
Patent MX-2012001415-A (MX)
Title: Hydrogel formulation comprising oxidative reductive potential water.
Inventor: NORTHEY ROBERT
IPC: A61K31/74
Filed: 2010-07-30
Abstract: The present invention relates to a hydrogel formulation containing an oxidative reduction potential (ORP) water solution and a gelling agent. The invention further provides a method for treating or preventing a condition in a patient comprising topically administering to a patient a therapeutically effective amount of a hydrogel formulation comprising an oxidative reductive potential solution and a gelling agent. A method for promoting wound healing in a patient is also provided.
Patent MX-2012004454-A (MX)
Title: System for determining unprocessed and partially processed neurotoxin type a.
Inventor: TAYLOR HAROLD V
IPC: G01N33/50
Filed: 2010-10-18
Abstract: The present invention is concerned with tools for the quality control and safety during manufacture of neurotoxins. In particular, it relates to a method for the determination of the amount of partially processed and/or unprocessed Botulinum neurotoxin A polypeptide (BoNT/A) in a solution comprising processed and partially processed and/or unprocessed BoNT/A comprising the steps of contacting a sample of said solution with a capture antibody which specifically binds to the partially processed and unprocessed BoNT/A under conditions which allow for binding of said antibody to said partially processed and unprocessed BoNT/A, whereby a complex is formed, and determining the amount of the formed complex, whereby the amount of the complex is indicative for the amount of the partially processed and/or unprocessed BoNT/A in said solution. Moreover, the present invention contemplates a device and a kit for carrying out said method.
Patent MX-2012005424-A (MX)
Title: Locking device for movable momentum connection in suppressors for semiautomatic and fully automatic weapons.
Inventor: LANDOLT ARMIN
IPC: F41A21/30
Filed: 2010-11-12
Abstract: The devices and assemblies of the invention allow the design and use of suppressors with at least two modes of operation and the suppressor can be reset significantly faster and more simply from a locked position into an unlocked position. The suppressors of the invention comprise a mounting ring (4) and a momentum part or assembly (5) that can be shifted axially, or along the axis of the barrel of the weapon. A pressure spring (23) is positioned between it and a column sleeve (1) of the silencer, which on the one hand presses the momentum part (5) against a projection (25) of the column sleeve (1) and on the other hand against the index disk (18). Interlocking cams (16) are positioned on the momentum part (5), which are blocked in a first position of the mounting ring (4), and in a second position of the mounting ring (4) they can be shifted so that the momentum part is unlocked and can move axially in response to firing. Rotating the mounting ring (4) allows the operator to switch from the first position into the second position, and lock or unlock the momentum part and the recoil booster function of the devices.
Patent MX-2012005924-A (MX)
Title: Method and system for thin chip digester cooking.
Inventor: ENGSTROM JOHAN
IPC: D21C3/02
Filed: 2010-11-19
Abstract: A method to cook thin chips in a continuous digester vessel including: introducing thin chips having a thickness of no more than 6mm, into a chip bin; adding white (cooking) liquor to the chip bin or to a chip transport passage extending from the chip bin to an upper inlet of the continuous digester vessel; injecting medium pressure steam or another heated fluid to an upper region of the digester vessel to elevate a cooking temperature of the chips in the vessel to at least 130 degrees Celsius; cooking the chips in the vessel as the chips flow downward through the vessel without substantial extraction or introduction of liquor in the cooking section of the vessel; injecting wash liquid to a lower region of the vessel; extracting at least wash liquid through a wash liquid extraction screen in the lower region of the vessel and above the injection of the wash liquid, and discharging the cooked thin chips from the lower region of the vessel.
Patent MX-2012007009-A (MX)
Title: Method for diagnosing malignant tumor.
Inventor: SAITO YASUSHI
IPC: G01N33/566
Filed: 2010-12-15
Abstract: Provided are a method for determining the presence of a malignant tumor or the severity thereof, selecting a therapeutic method therefor or evaluating the effect of said therapeutic method, or estimating the recurrence risk of said malignant tumor or the presence or absence of the recurrence of the same, and a diagnostic kit for the same purposes. The method for determining the presence of a malignant tumor or the severity thereof, selecting a therapeutic method therefor or evaluating the effect of said therapeutic method, or estimating the recurrence risk of said malignant tumor or the presence or absence of the recurrence of the same is characterized by comprising: a step (1) for measuring the concentration and/or quantity of soluble LR11 in a sample originating in a subject; and a step (2) for comparing the measurement data with the measurement data of soluble LR11 obtained from a group of normal subjects.
Patent MX-2012007690-A (MX)
Title: Method for producing expandable styrene polymer particles having reduced thermal conductivity.
Inventor: KUBIETZ NORBERT
IPC: C08J9/20
Filed: 2012-03-26
Abstract: The invention relates to a method for producing expandable styrene polymer particles having improved thermal conductivity by the polymerization of styrene in an aqueous suspension in the presence of a nucleating agent and a volatile blowing agent, wherein 10 to 5000 ppm, relative to the vinyl aromatic monomers, of a triglyceride of a hydroxy-C<sub>16</sub> to -C<sub>18</sub> oleic acid is used as the nucleating agent.
Patent MX-2012009641-A (MX)
Title: Thermoplastic nanocomposite material based on nanocrystalline cellulose (ncc).
Inventor: SU SHUNXING
IPC: C08L33/12
Filed: 2011-02-01
Abstract: A green approach for the development of nanocomposite materials comprising nanocrystalline cellulose (NCC) and appropriate vinyl polymers is conceived. The approach deals with the in-situ graft co-polymerization of hydrophobic vinyl monomers, such as vinyl acetate and methyl methacrylate, onto the NCC surface in an aqueous medium. The resulting material is significantly more hydrophobic and thermally stable than the starting NCC. The nanocomposite material can be suspended in appropriate solvents, dried and moulded with other materials using conventional polymer processing techniques to develop yet new materials with new characteristics. These nanocomposites have wide ranging applications from industrial to medical use.
Patent MX-2012010210-A (MX)
Title: Non-pvc film and non-pvc film laminate.
Inventor: SHIH FRANK Y
IPC: B32B27/00
Filed: 2011-03-04
Abstract: The present invention relates to a non-PVC film and film laminate for use in marketing, advertising campaigns, particularly outdoor or other environment impacted promotions and safety applications. The film is in one exemplary embodiment includes two layers, a top layer and a bottom layer. The top layer is a urethane-acrylic hybrid polymer and the bottom layer is a non-PVC based polymer. The film may be transparent, translucent, clear or have other desirable optical properties.
Patent MX-2012013469-A (MX)
Title: Levocarrimycin, pharmaceutical compositions, preparation methods and uses thereof.
Inventor: JIANG YANG
IPC: C12P19/62
Filed: 2011-05-25
Abstract: Disclosed are levocarrimycin, pharmaceutical compositions, preparation methods and uses thereof. Levocarrimycin is a mixture of isovalerylspiramycin III, II and I as main components and contains certain content of isobutyrylspiramycin III and II, butyrylspiramycin III and II, propionylspiramycin III and II, as well as acetylspiramycin III and II, wherein the content of isovalerylspiramycin III is not less than 30 wt%, the total content of isovalerylspiramycin III,II and I is not less than 60 wt%, and the content of acylspiramycin is 80-98 wt%. Specific optical rotation of said levocarrimycin is [Î±]D = -52Â° ~ -57Â° in the solution of 0.02g/ml chloroform at temperature of 25Â°C. Also disclosed are levocarrimycin comprising the crystal of isovalerylspiramycin III, II or I, and pharmaceutical compositions containing said levocarrimycin. The active components in levocarrimycin or its pharmaceutical compositions has optical activity and excellent anti-infective effect.
Patent MX-2012014146-A (MX)
Title: Method for cultivating sugar cane.
Inventor: WERNER FRANK
IPC: A01N47/40
Filed: 2011-06-08
Abstract: The present invention relates to a method for cultivating sugar cane comprising planting sugar cane shoots in a growth medium, growing seedlings from the shoots at a temperature of at least 15Â°C and 10-120 days after having planted the shoots planting the seedlings obtained therefrom into the field if the growth medium is not a field, or, in case the growth medium is a field, exposing the seedlings obtained from the shoots to ambient conditions, where the seedling, while growing, is treated with at least one strobilurin fungicide and/or at least one carboxamide fungicide and/or at least one GABA antagonist insecticide and/or at least one nicotinic receptor agonists/antagonist insecticide and/or at least one chloride channel activator insecticide.
Patent MX-2013005636-A (MX)
Title: Process using bisphenol a aminated and alkoxylated derivative as demulsifier.
Inventor: RIFF ISABELLE
IPC: C10G33/04
Filed: 2011-11-15
Abstract: Embodiments of the present disclosure include a method of destabilizing a crude oil-water emulsion that includes adding to the crude oil-water emulsion a demulsifier obtained by an alkoxylation reaction of an aminated epoxy adduct, the aminated epoxy adduct obtained by a reaction of an epoxy resin and an amine. In one or more embodiments, the alkoxylation reaction includes reacting C2 to C4 alkylene oxides with the aminated epoxy adduct.
Patent MX-2013012614-A (MX)
Title: Method for removing unmodified hemoglobin from cross-linked hemoglobin solutions including polymeric hemoglobin with high temperatures short time heat treatment apparatus.
Inventor: WONG BING LOU
IPC: C07K1/14
Filed: 2012-04-23
Abstract: A method heat treatment of cross-linked hemoglobin solutions including polymeric hemoglobin is disclosed. The method involves contacting the hemoglobin solution with a high temperature short time heat treatment apparatus. The high temperature short time process thermally denatures unmodified tetrameric hemoglobin (hemoglobin dimer form), protein impurities (e.g. immunoglobin-G, serum albumin), bacteria, and viruses so that renal injury, vascular detrimental effects and other toxicity reactions can be avoided.
Patent MX-2014005213-A (MX)
Title: Method for the thermal preparation of an auxiliary material and preparation unit.
Inventor: HOLLER SEBASTIAN
IPC: B05B16/00
Filed: 2012-10-31
Abstract: In order to provide a method for the thermal preparation of an auxiliary material, which, to clean a stream of untreated gas laden with an organic impurity, can be introduced into the stream of untreated gas and together with the organic impurity forms a stable system comprising the impurity and the auxiliary material, that can be carried out easily and with sparing use of resources, it is proposed that the method comprises the following steps: feeding the system comprising the impurity and the auxiliary material and a stream of carrier gas heated with respect to standard conditions into a thermal preparation device; chemically converting at least part of the organic impurity to produce a prepared auxiliary material; separating the prepared auxiliary material from the auxiliary material laden with an organic impurity by transporting it by means of a gas flow; and removing the prepared auxiliary material from the thermal preparation device.
Patent MX-2014005318-A (MX)
Title: Gene therapy for diabetic neuropathy using an hgf isoform.
Inventor: KIM JONG MOOK
IPC: A61K38/17
Filed: 2012-03-27
Abstract: The present invention relates to a pharmaceutical composition for the prevention or treatment of diabetic neuropathy, wherein the pharmaceutical composition comprises, as active ingredients, different types of isoforms of HGF or a polynucleotide encoding the isoforms. The present invention is the first invention demonstrating that diabetic neuropathy can be prevented and treated using different types of isoforms of HGF. According to the present invention, it is possible to very effectively treat diabetic neuropathy.
Patent MX-2014005796-A (MX)
Title: Apparatus and method for influencing and/or detecting magnetic particles having a large field of view.
Inventor: BONTUS CLAAS
IPC: A61B5/05
Filed: 2012-11-13
Abstract: The present invention relates to an apparatus and a method for influencing and/or detecting magnetic particles in a field of view (28), in particular for examination of human patients. The apparatus comprises i) selection-and-focus means (120) for generating a magnetic selection-and-focus field (50), wherein said at least one set of selection-and-focus field coils comprises -at least one inner selection-and-focus field coil (113, 115) being formed as a closed loop about an inner coil axis (115a),first inner selection-and-focus field coil (115) -a group of at least two outer selection-and-focus field coils (116-119) arranged at a larger distance from said inner coil axis (115a) than said at least one inner selection-and- focus field coil (113, 115) and at different angular positions, each being formed as a closed loop about an associated outer coil axis (116a-119a), and ii) drive means (120) comprising a drive field signal generator unit (122) and drive field coils (124; 125, 126, 127) for changing the position in space and/or size of the two sub-zones (52, 54) in the field of view (28) by means of a magnetic drive field so that the magnetization of the magnetic material changes locally.